Controversies: molecular vs. clinical systemic sclerosis classification
Johnson S, Hinchcliff M, Asano Y. Controversies: molecular vs. clinical systemic sclerosis classification. Journal Of Scleroderma And Related Disorders 2016, 1: 277-285. DOI: 10.5301/jsrd.5000213.Peer-Reviewed Original ResearchSystemic sclerosisMolecular classificationClassification of SScAutoimmunity/inflammationDisease-related autoantibodiesPopulation-based studyClinical classification systemDaily clinical practiceCardinal pathological featuresMultisystem chronic diseaseMolecular targeting therapyEstimates of outcomesComplex heterogeneous disorderInternal organ diseaseSkin sclerosisLaboratory featuresSSc patientsClinical presentationPathological featuresUnknown etiologyClassification systemChronic diseasesOrgan diseaseIndividual patientsPotential responders